APA citiranje

Fountzilas, G., Valavanis, C., Kotoula, V., Eleftheraki, A. G., Kalogeras, K. T., Tzaida, O., . . . Arapantoni, P. (2012). HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy. BioMed Central.

Citação norma Chicago

Fountzilas, George, et al. HER2 and TOP2A in High-risk Early Breast Cancer Patients Treated With Adjuvant Epirubicin-based Dose-dense Sequential Chemotherapy. BioMed Central, 2012.

MLA citiranje

Fountzilas, George, et al. HER2 and TOP2A in High-risk Early Breast Cancer Patients Treated With Adjuvant Epirubicin-based Dose-dense Sequential Chemotherapy. BioMed Central, 2012.